Achilles Therapeutics plc Quarterly Common Stock, Shares Authorized from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Achilles Therapeutics plc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 41.1M shares, a 0.35% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 41.1M +142K +0.35% Jun 30, 2024 6-K 2024-08-14
Q4 2023 41.1M +150K +0.37% Dec 31, 2023 6-K 2024-08-14
Q2 2023 40.9M Jun 30, 2023 6-K 2023-08-04
Q4 2022 40.9M +329K +0.81% Dec 31, 2022 20-F 2024-04-04
Q4 2021 40.6M +36.2M +825% Dec 31, 2021 20-F 2023-03-07
Q4 2020 4.39M Dec 31, 2020 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.